SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-020687
Filing Date
2020-10-02
Accepted
2020-10-02 17:02:07
Documents
14
Period of Report
2020-09-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20201002_8k.htm   iXBRL 8-K 25655
6 mbrx20201002_8kimg001.jpg GRAPHIC 3620
  Complete submission text file 0001437749-20-020687.txt   172734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20200930.xsd EX-101.SCH 3700
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20200930_def.xml EX-101.DEF 11972
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20200930_lab.xml EX-101.LAB 16010
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20200930_pre.xml EX-101.PRE 12181
7 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20201002_8k_htm.xml XML 2656
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 201221011
SIC: 2834 Pharmaceutical Preparations